Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue $ 761  
Operating expenses    
Research and development (21,264) $ (22,019)
General and administrative (9,261) (11,773)
Total operating expenses (30,525) (33,792)
Operating loss (29,764) (33,792)
Interest income 730 952
Other income, net 937 5,430
Loss before income taxes (28,097) (27,410)
Income tax expense (70) (2)
Net loss attributable to ordinary shareholders $ (28,167) $ (27,412)
Net loss per ordinary share - Basic and diluted    
Basic and diluted (in dollars per share) $ (0.04) $ (0.04)
Weighted average shares outstanding:    
Basic and diluted (in shares) 739,753,371 627,945,243